US Patent Issued to The Regents of the University of California on March 18 for "Anti-CD46 antibodies and methods of use" (California, Colorado Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,746, issued on March 18, was assigned to The Regents of the University of California (Oakland, Calif.).

"Anti-CD46 antibodies and methods of use" was invented by Bin Liu (San Francisco), Daniel W. Sherbenou (Denver), Blake T. Aftab (Thousand Oaks, Calif.), Yang Su (South San Francisco, Calif.) and Christopher R. Behrens (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of treating a subject having a cancer characterized by a modification at biomarker 1q21, which comprises administering to the subject a therapeutically effective amount of an anti-CD46 antibody."

The patent was filed on July 27, 2022, under A...